Bora Pharmaceuticals Co., Ltd. (TPE:6472)
311.00
-33.50 (-9.72%)
Nov 19, 2026, 1:30 PM CST
Bora Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Bora Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $576.47. The average 1-year stock price forecast is 85.36% higher than the current stock price, while the lowest is $462.00 (+48.55%) and the highest is $729.29 (+134.50%).
Price Target: $576.47 (+85.36%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bora Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 7 |
Financial Forecast
Revenue This Year
22.78B
from 19.01B
Increased by 19.83%
Revenue Next Year
29.02B
from 22.78B
Increased by 27.36%
EPS This Year
24.99
from 23.24
Increased by 7.53%
EPS Next Year
31.27
from 24.99
Increased by 25.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.